DEA: Two Specific Kratom Studies
Tracking # |
17-00233-F |
Submitted | Jan. 9, 2017 |
MuckRock users can file, duplicate, track, and share public records requests like this one. Learn more.
Communications
From: anthony roberts
To Whom It May Concern:
This is a request under the Freedom of Information Act. I hereby request the following records:
I am seeking all communications with or within the DEA that references either of the following studies:
Monitoring of kratom or Krypton intake in urine using GC-MS in clinical and forensic toxicology. Anal Bioanal Chem. 2011 Apr;400(1):127-35. doi: 10.1007/s00216-010-4464-3. Epub 2010 Dec 12. Philipp AA, Meyer MR, Wissenbach DK, Weber AA, Zoerntlein SW, Zweipfenning PG, Maurer HH. Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Saarland University, 66421 Homburg, Saar, Germany.
Forensic Sci Int. 2011 May 20;208(1-3):47-52. doi: 10.1016/j.forsciint.2010.10.025. Epub 2010 Nov 26. Kratom alkaloids and O-desmethyltramadol in urine of a "Krypton" herbal mixture consumer. Arndt T, Claussen U, Güssregen B, Schröfel S, Stürzer B, Werle A, Wolf G. Bioscientia, Institut für Medizinische Diagnostik GmbH, Ingelheim, Germany. torsten.arndt@bioscientia.de
This should include newsletters, emails, internal memorandum, and any other documents or communications that indicate that either of these studies, or both, are in possession by the agency, and when the agency came into said possession.
The requested documents will be made available to the general public, and this request is not being made for commercial purposes.
In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.
Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.
Sincerely,
anthony roberts
From: Drug Enforcement Administration
An acknowledgement letter, stating the request is being processed.
From: MuckRock.com
To Whom It May Concern:
I wanted to follow up on the following Freedom of Information request, copied below, and originally submitted on Jan. 9, 2017. Please let me know when I can expect to receive a response, or if further clarification is needed. You had assigned it reference number #17-00233-F.
Thanks for your help, and let me know if further clarification is needed.
From: MuckRock.com
To Whom It May Concern:
I wanted to follow up on the following Freedom of Information request, copied below, and originally submitted on Jan. 9, 2017. Please let me know when I can expect to receive a response, or if further clarification is needed. You had assigned it reference number #17-00233-F.
Thanks for your help, and let me know if further clarification is needed.
From: MuckRock.com
To Whom It May Concern:
I wanted to follow up on the following Freedom of Information request, copied below, and originally submitted on Jan. 9, 2017. Please let me know when I can expect to receive a response, or if further clarification is needed. You had assigned it reference number #17-00233-F.
Thanks for your help, and let me know if further clarification is needed.
From: DEA.FOIA
Good Evening Mr. Roberts:
As a courtesy to you, this is in regard to your email dated 4/19/17 asking about the status of your request, 17-00233-F. As a courtesy attached is a copy of the reformulation letter dated 1/30/17 mailed to the address given in your initial FOIA request on 01/09/17. If you have any questions with regard to your FOI Request you may contact the assigned GIS Specialist J. Edmonds
Respectfully yours,
Jewell Carroll
Program Specialist
Freedom of Information/Privacy Act Unit (SARF)
(Desk) 202-307-4006; (fax) 202-307-8556
FOIA/PA Main Phone Line 202-307-7596
Files
pages